Organic Process Research and Development p. 1227 - 1238 (2016)
Update date:2022-08-03
Topics:
Williams, Michael J.
Chen, Qinghao
Codan, Lorenzo
Dermenjian, Renee K.
Dreher, Spencer
Gibson, Andrew W.
He, Xianliang
Jin, Yan
Keen, Stephen P.
Lee, Alfred Y.
Lieberman, David R.
Lin, Wei
Liu, Guiquan
McLaughlin, Mark
Reibarkh, Mikhail
Scott, Jeremy P.
Strickfuss, Sophie
Tan, Lushi
Varsolona, Richard J.
Wen, Feng
We describe the route development and multikilogram-scale synthesis of an HCV NS5B site D inhibitor, MK-8876. The key topics covered are (1) process improvement of the two main fragments; (2) optimization of the initially troublesome penultimate step, a key bis(boronic acid) (BBA)-based borylation; (3) process development of the final Suzuki-Miyaura coupling; and (4) control of the drug substance form. These efforts culminated in a 28 kg delivery of the desired active pharmaceutical ingredient.
View MoreContact:86 311 85902108 / 85902109
Address:room 1001-1005 ,huanghe Road ,shijiazhuang ,China
Jinan Kaypharm Chemical Co.,Ltd
Contact:86-0531-86986780
Address:Room101,No189-2,Huayuan Road,Jinan City,Shandong Province
Shanghai Mintchem Development ., Ltd
Contact:0086 21 5190 8570
Address:R602,4#,89Nong, Mudan Road Pudong Shanghai China
Chengdu Biopurify Phytochemicals Ltd.
website:http://www.phytopurify.com
Contact:+86-28-82633397
Address:2F,No.11 Building,No.388 Rongtaidadao CNSTP,Wenjiang Zone,Chengdu,Sichuan, China
Contact:+86 21 5017 5386
Address:No 999,Jiangyue Rd, Minhang Dist ,201114,Shanghai ,China
Doi:10.1016/0040-4039(94)02477-S
(1995)Doi:10.1038/nchem.2904
(2018)Doi:10.1021/jm050867d
(2006)Doi:10.1248/cpb.43.100
(1995)Doi:10.1021/op500222p
(2014)Doi:10.1016/j.bmcl.2014.07.019
(2014)